Navigation Links
Global NASH Therapeutics Market to Record 30% CAGR Through 2017, According to GlobalData Report Published at

London, UK (PRWEB) November 04, 2013

Currently, the nonalcoholic steatohepatitis (NASH) market environment is very sparse on the back of high levels of unmet clinical and environmental needs for NASH, including approved therapies specific to NASH, physician education as well as patient awareness. The disease’s heterogeneous nature combined with its slow progression represents serious challenge in developing new drugs and designing innovative diagnostic tools.

In 2012, the world NASH market stood at around USD 233 million. It is likely to grow at a 30% CAGR to surpass the USD 862.9 billion mark by 2017. The market growth will be boosted considerably by the increasing prevalence of diabetes and obesity worldwide. The US is forecast to hold the lion’s share of the world NASH market, contributing around USD 827 million towards overall sales. It is likely to be followed by the top five European country markets (Germany, France, Spain, the UK and Italy).

In-demand research report “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017” elaborated by GlobalData has been recently published by Market Publishers Ltd.

Report Details:

Title: OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017
Published: September, 2013
Pages: 128
Price:    US$ 5,995.00

The report provides in-depth unbiased insights into the global NASH therapeutics market. It presents a comprehensive profile of NASH, encompassing details about the disease its epidemiology, symptoms, pathology, diagnosis and treatment. The study covers the actual market performance as well as sheds light on the historical development of the market, offers extensive pipeline analysis including vital information on the important trends and developments. It uncovers estimates of annual therapy cost and treatment pattern for the 2012-2017 period, examines the key factors driving and restraining the industry growth, and also contains a strategic clinical and commercial benchmarking assessment of the pipeline and standard of care. Moreover, the market future outlook through 2019 is available in the report.

Report Scope:

  •     Insightful overview of the global NASH therapeutics market.
  •     Comprehensive disease profile including vital information on the disease epidemiology, symptoms, pathology, diagnosis and treatment.
  •     Review of the current treatment options.
  •     Thorough examination of unmet needs and analysis of the major opportunities in the NASH therapeutics market.
  •     Important data on NASH R&D strategies.
  •     Pipeline assessment and pipeline valuation analysis.
  •     Estimates of annual therapy cost and treatment usage for the 2012-2017 period.
  •     Market future outlook through 2019.

More insightful research reports by the publisher can be found at GlobalData page.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
(Date:10/9/2015)... , ... October 09, 2015 , ... With the FCPX ... pop grades to footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. This pack comes with 60 vibrant CUBE LUT files. ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... in The Tennessean's eighth annual Toast of Music City, a reader’s choice awards ... residents nominated and cast votes for their favorite businesses in over 200 categories, ...
(Date:10/9/2015)... ... ... On Saturday, September 26, 2015, 48-year-old MS survivor and entrepreneur Lucie B won ... USA and Sweden in the Speed and Power events, which consisted of 30-Second Single ... 1 Silver and 4 Gold Medals. , “I remember looking at my competitors and ...
(Date:10/9/2015)... ... 2015 , ... "As a nurse, I care for male patients who struggle ... wear large diapers or pads. We came up with this as a better alternative ... leaking from the tip of the penis. This prevents stains from forming on underwear ...
(Date:10/9/2015)... ... October 09, 2015 , ... Santa Rosa Consulting and The ... MD Anderson prepares to go-live on the Epic platform in March of 2016. Both ... Santa Rosa will execute the contract by supporting Scheduling Appointment Conversion and the Go-Live. ...
Breaking Medicine News(10 mins):
... eye of now co-editor Rick Drake and colleagues at the ... now the highest ranking journal in science education? If ... correct! As AAA publisher Wiley-Blackwell put it in a ... as the number 1 ranked journal in Education, Scientific Disciplines." ...
... scientists at Duke University Medical Center and Johns Hopkins ... of drug therapy to treat the second most common ... been looking for the primary cancer genes involved in ... that held the probable mutations, but not the particular ...
... Summer for most people means time spent outdoors, which ... arthropod-borne diseases, such as "rickettsial diseases" infectious diseases ... fleas, ticks and mites. Now a $1.6 million ... enable an entomologist at the University of California, Riverside ...
... Southwestern Medical Center researchers may suggest new strategies for successful ... such as leukemia, lymphoma and myeloma. The study, published ... the first time that adult blood stem cells can be ... rejection. It also opens up further studies in stem cell ...
... and are famous for their "work hard, play ... employees healthier too? According to a Tel Aviv University ... health benefits. Dr. Sharon Toker of the ... School of Business Administration says that employees who believe ...
... By Ellin Holohan HealthDay Reporter , THURSDAY, ... antidepressants than ever before to deal with everyday stress, ... to patients with no mental health diagnosis, a new ... Lexapro are now the third most widely prescribed group ...
Cached Medicine News:
(Date:10/9/2015)... , Oct. 9, 2015  Impax Laboratories, Inc. ... will release its third quarter 2015 financial results on ... the U.S. financial markets. The Company will host a ... at 8:30 a.m., Eastern Time on November 9, 2015.  ... . --> The financial results and live ...
(Date:10/9/2015)... 9, 2015 Eli Lilly and Company (NYSE: ... and approximately 50 new jobs to its research and development ... New York, New York . ... space will include a translational immuno-oncology hub and a Lilly ... collaborative access to cutting-edge drug discovery capabilities, including chemistry and ...
(Date:10/9/2015)...   --> --> Phase ... San Diego, California , by Dr. Tom Lyon , ... Center, on 9 th October 2015 at 8:30a.m. PDT. ... Tom Lyon , Director of Orthopaedics and Chief of Orthopaedic Trauma, ... 8:30a.m. PDT. --> Kuros Biosurgery AG, a biotechnology company ...
Breaking Medicine Technology:
... Talecris Biotherapeutics (Nasdaq: TLCR ) today ... Administration for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more ... manufacturing technology. , Like PROLASTIN, the market leader ... the treatment of alpha1-antitrypsin (AAT) deficiency, a genetic ...
... BRIDGEWATER, N.J., Oct. 16 Sanofi-aventis U.S. announced that ... marketing approval for Elitek® (rasburicase) to be used for ... in adult patients with leukemia, lymphoma, and solid tumor ... in tumor lysis syndrome (TLS) and subsequent elevations of ...
Cached Medicine Technology:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: